{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:41:37Z","timestamp":1787064097154,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.clindermatol.2011.06.018","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T12:46:56Z","timestamp":1345121216000},"page":"492-495","source":"Crossref","is-referenced-by-count":5,"title":["Ethical considerations when prescribing biologics in dermatology"],"prefix":"10.1016","volume":"30","author":[{"given":"Frank A.","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti J.","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Strober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2011.06.018_bb0005","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archdermatol.2010.370","article-title":"Prevalence of the metabolic syndrome in psoriasis: results from the national health and nutrition examination survey, 2003-2006","volume":"147","author":"Love","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0020","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0025","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0030","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/ard.2010.129916","article-title":"Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis","volume":"70","author":"Greenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.06.018_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.2008.08781.x","article-title":"Long-term data in the treatment of psoriasis","volume":"159","author":"Tha\u00e7i","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","article-title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","volume":"158","author":"Saurat","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaad.2009.12.029","article-title":"Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial","volume":"63","author":"Reich","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0055","first-page":"1442","article-title":"Conventional systemic agents for psoriasis. A systematic review","volume":"33","author":"Strober","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0060","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaad.2008.12.031","article-title":"Treatments for psoriasis and the risk of malignancy","volume":"60","author":"Patel","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14656566.7.2.157","article-title":"Cost-effectiveness of moderate-to-severe psoriasis treatment","volume":"7","author":"Miller","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0075","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1365-2133.2008.08962.x","article-title":"Economic evaluation of systemic therapies for moderate to severe psoriasis","volume":"160","author":"Sizto","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0080","unstructured":"American Medical Association. The facts about pharmaceutical marketing & promotion. 2008. Available at: http:\/\/www.ama-assn.org\/ama\/pub\/physician-resources\/legal-topics\/business-management-topics\/interactions-pharmaceutical-industry-representatives.shtml. Accessed December 20, 2010."},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D39H81C13S","article-title":"Drug representatives: giving you lunch or stealing your soul?","volume":"13","author":"Higgins","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2011.06.018_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1067\/mjd.2002.120469","article-title":"Off-label prescribing in the treatment of dermatologic disease","volume":"47","author":"Sugarman","year":"2002","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T13:28:35Z","timestamp":1643203715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X11001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0738081X11001581"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2011.06.018","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}